ArticleThe Journal of clinical investigation2023

Inhibition of DPAGT1 suppresses HER2 shedding and trastuzumab resistance in human breast cancer.

Muwen Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.